PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

I highly doubt something approved as s copy in the veterinary...

  1. 102 Posts.
    lightbulb Created with Sketch. 7
    I highly doubt something approved as s copy in the veterinary world has gone through the same hoops that the FDA would require for it to be classed a generic. DYOR




 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.